Publication | Closed Access
Ultrasmall Rhodium Nanozyme with RONS Scavenging and Photothermal Activities for Anti-Inflammation and Antitumor Theranostics of Colon Diseases
190
Citations
31
References
2020
Year
NanoparticlesNanotherapeuticsUltrasmall Rhodium NanodotsEngineeringBiomedical EngineeringChemistryProtein NanoparticlesPolyethylene GlycolNanomedicineTherapeutic NanomaterialsBioimagingChemodynamic TherapyMatrix BiologyRadiation OncologyMolecular ImagingNanobiotechnologyColon DiseasesTumor TargetingRhodium NanozymeMolecular EngineeringColitis-associated Colorectal CancerBiomolecular EngineeringPharmaceutical NanotechnologyDrug Delivery SystemsNano-drug DeliveryMedicinePhotothermal ActivitiesSmall Molecules
Colitis-associated colorectal cancer (CAC), in which chronic inflammation is a well-recognized carcinogen, requires concurrent anti-inflammation and antitumor treatments in the clinic. Herein, we report polyethylene glycol (PEG)-coated (PEGylated) ultrasmall rhodium nanodots (Rh-PEG NDs) can serve as a metallic nanozyme with reactive oxygen and nitrogen species (RONS) scavenging properties as well as photothermal activities for anti-inflammation and antitumor theranostics in colon diseases. Benefiting from multienzyme activities against RONS, Rh-PEG NDs can decrease the levels of pro-inflammatory cytokines (TNF-α, IL-6), resulting in good anti-inflammatory effect on dextran sulfate sodium-induced colitis. By virtue of high photothermal conversion efficiency (48.9%), Rh-PEG NDs demonstrate complete ablation of CT-26 colon tumor without any recurrence. Most importantly, Rh-PEG NDs exhibit good biocompatibility both at the cellular and animal levels. Our findings provide a paradigm to utilize metallic nanozymes for the potential management of colon diseases.
| Year | Citations | |
|---|---|---|
Page 1
Page 1